Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
86,210,177
Share change
+5,007,284
Total reported value
$2,579,382,908
Put/Call ratio
336%
Price per share
$29.92
Number of holders
129
Value change
+$148,626,753
Number of buys
78
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q4 2019

As of 31 Dec 2019, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,210,177 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, Senator Investment Group LP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, TimesSquare Capital Management, LLC, TIGER MANAGEMENT L.L.C., BAKER BROS. ADVISORS LP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 129 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.